Since 1997, Oakwood Laboratories has been committed to developing global pharmaceutical products, using our Chroniject™ technology platform, that provide enhanced therapeutic benefits to patients worldwide throughout a variety of disease states. Oakwood is also dedicated to adhering to the highest quality standards for all projects, while maintaining successful alliances with strategic partners globally.